Skip to main content
. 2018 Jul 6;13(7):e0197561. doi: 10.1371/journal.pone.0197561

Table 1. Association of variants in small GTPase genes with epithelial ovarian cancer risk (p-value<10−4) and functional annotation.

Genetic Association Functional Annotation
Gene SNP Chr:Position Alleles
MAF Histology OR (95% CI) P-value Conserved site eQTL Tissues with enhancer histone mark Tissues with DNAse site In super-enhancer
ARHGEF10L rs2256787 1:17,765,403 A/C 0.07 Endometrioid 1.33 (1.18–1.50) 4.5 x 10−6 No No ESC, ESDR, IPSC, FAT, STRM, BRST, BRN, SKIN, VAS, LIV, GI, HRT, MUS, LNG, OVRY, PANC None Yes
rs10788679 1:17,789,549 A/G 0.42 Serous 1.07 (1.03–1.11) 2.6 x 10−4 No No None None Yes
AKAP6 rs1955513 14:32,245,693 C/A 0.07 All invasive 0.90 (0.85–0.95) 3.3 x 10−4 Yes No FAT, SKIN, VAS, BRN, MUS, GI, BLD SKIN,MUS,MUS,THYM,BLD No
rs927062 14:32,164,800 G/A 0.21 All invasive 0.94 (0.90–0.97) 5.9 x 10−4 No Yes, ARHGAP5 None GI No

SNP, single nucleotide polymorphism; alleles show minor/major; MAF, minor allele frequency; OR, odds ratio; CI, confidence interval; eQTL, expression quantitative locus with p<0.05 in EOC tumors; histone marks and DNAse I hypersensitive sites from HaploReg v 4.1 indicating tissue types as defined therein; super enhancer information based on the human super-enhancer database available at http://bioinfo.au.tsinghua.edu.cn/dbsuper/index.php; none of these SNPs had previous GWAS associations with any phenotype based on the EBI GWAS catalog or resided within promoter histone marks; all SNPs are intronic to the gene indicated.